europe within 10 weeks, page-2

Apart from fonda revenue for the last quarter, all announcements since Xmas have been +ve. Alchemia has more going for it than a number of smaller cap biotech companies that have had substantial sp rises in recent months. At some stage the tide will turn in a big way (and i don't know what the catalyst will be) but at this point in time I suspect ACL could announce it had the recipe for the elixir of youth and the sp wouldn't budge!